Aventa FusionPlus: The 3D Genomics Solution to Diagnostic Dilemmas in Solid Tumors

Wednesday, November 20, 2024

3:00 PM – 3:50 PM PST

Location: 221 & 222, Level 2

Corporate Workshop Speaker(s)

AS

Anthony Schmitt, PhD

SVP of Science
Arima Genomics
Carlsbad, California, United States
Anthony M. Magliocco, MD, FRCPC, FCAP (he/him/his)

President and CEO
Protean Biodiagnostics
Orlando, Florida, United States
CR

Chris Roberts

Chief Product Officer
Arima Genomics

In this workshop, explore the groundbreaking application of 3D genomics in tumor diagnostics and therapeutic selection. Discover how 3D genomics identifies clinically actionable fusions and complex structural rearrangements that traditional methods miss. Learn how the Aventa FusionPlus test can be used to:

• Double the detection rate of gene fusions (NTRK, ROS1, EGFR, RET, ALK) in patients who may be eligible for targeted therapies
• Increase the detection rate of deleterious HRR mutations in patients who may be eligible for PARP inhibitors
• Resolve diagnostic dilemmas in translocation-driven tumors